These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2515260)
21. Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: old and new. Korvick J; Yu VL; Hilf M Diagn Microbiol Infect Dis; 1987 Jun; 7(2):107-11. PubMed ID: 3115670 [TBL] [Abstract][Full Text] [Related]
22. [Tricentric study of the sensitivity of Pseudomonas aeruginosa serotyping to beta-lactams and aminoglycosides]. Vachée A; Scheftel JM; Husson MO; Izard D; Ross P; Monteil H Pathol Biol (Paris); 1997 May; 45(5):357-62. PubMed ID: 9296084 [TBL] [Abstract][Full Text] [Related]
23. In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014). Nichols WW; de Jonge BL; Kazmierczak KM; Karlowsky JA; Sahm DF Antimicrob Agents Chemother; 2016 Aug; 60(8):4743-9. PubMed ID: 27216074 [TBL] [Abstract][Full Text] [Related]
24. [The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum]. Fujiue Y; Kuwabara M; Muroki K; Shimizu S; Watanabe Y; Awaya Y; Kodomari Y Jpn J Antibiot; 1998 Jan; 51(1):26-36. PubMed ID: 9557274 [TBL] [Abstract][Full Text] [Related]
25. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa]. Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765 [TBL] [Abstract][Full Text] [Related]
26. Susceptibility of Pseudomonas pseudomallei to new beta-lactam and aminoglycoside antibiotics. McEniry DW; Gillespie SH; Felmingham D J Antimicrob Chemother; 1988 Feb; 21(2):171-5. PubMed ID: 3162898 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Pseudomonas aeruginosa alginate expression by subinhibitory concentrations of antibiotics. Majtán V; Hybenová D Folia Microbiol (Praha); 1996; 41(1):61-4. PubMed ID: 9090826 [TBL] [Abstract][Full Text] [Related]
28. In vitro comparison of cefpirome and four other beta-lactam antibiotics alone and in combination with tobramycin against clinical isolates of Pseudomonas aeruginosa. Cabezudo I; Pfaller M; Bale M; Wenzel R Diagn Microbiol Infect Dis; 1989; 12(4):337-41. PubMed ID: 2512048 [TBL] [Abstract][Full Text] [Related]
30. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics. Apropos of 338 strains isolated at the Regional Hospital Center at Nantes in 1984]. Reynaud AE; Coude du Foresto B; Espaze EP; Courtieu AL Pathol Biol (Paris); 1987 Sep; 35(7):1023-6. PubMed ID: 3118324 [TBL] [Abstract][Full Text] [Related]
31. The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa. Rolston KV; Chandrasekar PH; LeFrock JL; Schell RF Chemotherapy; 1984; 30(1):31-4. PubMed ID: 6420119 [TBL] [Abstract][Full Text] [Related]
32. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests. Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985 [TBL] [Abstract][Full Text] [Related]
33. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. Chen HY; Yuan M; Ibrahim-Elmagboul IB; Livermore DM J Antimicrob Chemother; 1995 Apr; 35(4):521-34. PubMed ID: 7628986 [TBL] [Abstract][Full Text] [Related]
34. Pseudomonas aeruginosa isolated from corneal ulcer: susceptibility to antimicrobial agents tested alone or in combination. Hu FR; Luh KT J Formos Med Assoc; 1992 Feb; 91(2):190-4. PubMed ID: 1364217 [TBL] [Abstract][Full Text] [Related]
35. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis]. Croize J; Gout JP; Robert J; Le Noc P Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041 [TBL] [Abstract][Full Text] [Related]
36. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams. Lerner SA; Quinn JP Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267 [TBL] [Abstract][Full Text] [Related]
37. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps. Azimi L; Rastegar Lari A Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949 [TBL] [Abstract][Full Text] [Related]
38. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin]. Wundt W; Lange KP; Baumgärtner M Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123 [TBL] [Abstract][Full Text] [Related]
39. Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa. Baltch AL; Bassey C; Hammer MC; Smith RP; Conroy JV; Michelsen PB J Antimicrob Chemother; 1991 Jun; 27(6):801-8. PubMed ID: 1938686 [TBL] [Abstract][Full Text] [Related]
40. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Cappelletty DM; Rybak MJ Antimicrob Agents Chemother; 1996 Mar; 40(3):677-83. PubMed ID: 8851592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]